Rhythm Pharmaceuticals (RYTM) Inventory (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Inventory data on file, last reported at $28.7 million in Q1 2026.

• On a quarterly basis, Inventory rose 48.33% year-over-year to $28.7 million in Q1 2026; TTM through Mar 2026 was $28.7 million, a 48.33% increase from a year earlier, with the FY2025 full-year figure at $25.8 million, up 37.42% from the prior year.
• Inventory for Q1 2026 stood at $28.7 million, up from $25.8 million in the prior quarter.
• Over the last five years, Inventory for RYTM reached as high as $28.7 million in Q1 2026 and fell as low as $2.9 million in Q4 2022.
• Historically, Inventory has averaged $14.2 million across 5 years, with a median of $12.9 million in 2024.
• Across the five-year window, Inventory surged 2527.93% in 2022 and soared 37.42% in 2025, its largest moves.
• Year by year, Inventory stood at $2.9 million in 2022, then soared by 195.65% to $8.6 million in 2023, then surged by 117.31% to $18.7 million in 2024, then soared by 37.42% to $25.8 million in 2025, then grew by 11.25% to $28.7 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $28.7 million in Q1 2026, $25.8 million in Q4 2025, and $22.1 million in Q3 2025.